Clinical Trials Browser

Neoplasms × aflibercept × Clear all

NCT02192541 2018-03-29

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Phase 1 Terminated

5 enrolled 15 charts

Neoplasms, Sarcoma

NCT01802684 2017-03-01

VELVET

Phase 2 Completed

Neoplasm Metastasis, Neoplasms

NCT02045030 2016-11-16

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00519285 2016-07-22

VENICE

Phase 3 Completed

1,224 enrolled 21 charts

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00327171 2016-06-07

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Phase 2 Completed

218 enrolled 19 charts

Neoplasms, Ovarian Neoplasms

NCT00082823 2016-06-03

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Phase 1 Completed

GastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmSarcoma

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Burkitt Lymphoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00083213 2016-06-03

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Phase 1 Completed

GastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmSarcoma

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Burkitt Lymphoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00876044 2016-05-05

QUTIE

Phase 1 Completed

Neoplasms

NCT01930552 2015-01-07

A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

Phase 1 Completed

Neoplasms

NCT00545246 2013-10-16

A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients

Phase 1 Completed

Neoplasms

NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Phase 2 Completed

98 enrolled 14 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01148615 2012-01-13

A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors

Phase 1 Completed

Neoplasms

NCT00479076 2011-01-26

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

Phase 1 Completed

Neoplasms